Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity

NCT04368897 is registered in ClinicalTrials.gov with Applied Biology, Inc. as lead sponsor.

NCT NCT04368897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04368897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity
Lead sponsor
Applied Biology, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
May 1, 2020
Completion date
December 1, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgen deficiency, androgen receptor abnormal, androgenetic alopecia, covid, covid-19, sars-cov 2